Follow the people · Insider
Susan Eylward
Susan Eylward files insider transactions with the SEC as a general counsel and corp sec of Imunon (IMNN). We hold 6 disclosed purchases and sales filed since 8 October 2024, 6 of them in the last 90 days.
- Files forIMNN
- Disclosed buys and sells6 in all, 6 in the last 90 days
- Last disclosure1 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 7 October 2024 — 31 August 2026General Counsel and Corp Sec · Imunon (IMNN)17 Form 4 lines · source: SEC Form 4
Everything they disclosed
17 entries, newest first — one per disclosure report, one per Form 4 line- was granted 2,525 shares of ImunonSEC Form 41 September 2026Common Stock · traded 28 August 2026 · filed 1 September 2026
- ▼ sold on the open market 2,525 shares of ImunonSEC Form 41 September 2026Common Stock · traded 31 August 2026 · filed 1 September 2026
- was granted 2,449 shares of ImunonSEC Form 417 August 2026Common Stock · traded 14 August 2026 · filed 17 August 2026
- ▼ sold on the open market 2,449 shares of ImunonSEC Form 417 August 2026Common Stock · traded 17 August 2026 · filed 17 August 2026
- was granted 2,541 shares of ImunonSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 2,541 shares of ImunonSEC Form 44 August 2026Common Stock · traded 3 August 2026 · filed 4 August 2026
- was granted 2,150 shares of ImunonSEC Form 421 July 2026Common Stock · traded 17 July 2026 · filed 21 July 2026
- ▼ sold on the open market 2,150 shares of ImunonSEC Form 421 July 2026Common Stock · traded 20 July 2026 · filed 21 July 2026
- was granted 920 shares of ImunonSEC Form 47 July 2026Common Stock · traded 2 July 2026 · filed 7 July 2026
- ▼ sold on the open market 920 shares of ImunonSEC Form 47 July 2026Common Stock · traded 6 July 2026 · filed 7 July 2026
- was granted 14,696 shares of ImunonSEC Form 429 June 2026Common Stock · traded 25 June 2026 · filed 29 June 2026
- ▼ sold on the open market 11,800 shares of ImunonSEC Form 429 June 2026Common Stock · traded 29 June 2026 · filed 29 June 2026
- was granted 8,251 shares of Imunon (a derivative holding)SEC Form 46 January 2026Stock Option (Right to Buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 8,251 shares of Imunon (a derivative holding)SEC Form 46 January 2026Stock Option (Right to Buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 417 shares of Imunon (a derivative holding)SEC Form 46 August 2025Stock Option (Right to Buy) · traded 4 August 2025 · filed 6 August 2025
- was granted 6,250 shares of Imunon (a derivative holding)SEC Form 418 March 2025Stock Option (Right to Buy) · traded 14 March 2025 · filed 18 March 2025
- was granted 50,000 shares of Imunon (a derivative holding)SEC Form 48 October 2024Stock Option (Right to Buy) · traded 7 October 2024 · filed 8 October 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.